Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2014	$ 16,762	$ 16,026,951	$ (15,231,903)	$ 811,810
Balance, shares at Dec. 31, 2014	16,761,911
Issuance of common stock in connection with the Merger (See Note 4)	13,592	14,935,736		14,949,327
Issuance of common stock in connection with the Merger (See Note 4), shares	13,591,533
Stock-based compensation expense		364,576
Issuance of common stock and warrants in connection with private placement	3,432	2,938,528		2,941,960
Issuance of common stock and warrants in connection with private placement, shares	3,432,314
Contribution of note and interest payable to Vaporin to capital in connection with the Merger		354,029		354,029
Cancellation of common stock as a result of early termination of consulting agreement	(150)	150
Cancellation of common stock as a result of early termination of consulting agreement, shares	(150,000)
Net income			(5,924,617)	(3,981,196)
Balance at Mar. 31, 2015	$ 33,636	$ 36,699,041	$ (19,213,099)	$ 17,519,578
Balance, shares at Mar. 31, 2015	33,635,758